Opportunity North East (ONE)(@Opportunity_NE1) 's Twitter Profile Photo

A. Sinclair Dunlop, Sarah Hardy, Andrew McNeill, Clare Terlouw and Gillian Bowditch, discussed what investors are looking for from entrepreneurs.

A. Sinclair Dunlop, Sarah Hardy, Andrew McNeill, Clare Terlouw and Gillian Bowditch, discussed what investors are looking for from #lifesciences entrepreneurs.

#timeslifesciencessummit
account_circle
Opportunity North East (ONE)(@Opportunity_NE1) 's Twitter Profile Photo

Professor Andrew Porter, Dr Abdo Alnabulsi, Marcus Wischik, David Tudor and Ernst van Orsouw discussed strategies for commercialisation.

A good exit? Financial return, sticky supply chain, jobs and skills = sustainable, high-value sector.

Professor Andrew Porter, Dr Abdo Alnabulsi, Marcus Wischik, David Tudor and Ernst van Orsouw discussed strategies for commercialisation.

A good exit? Financial return, sticky supply chain, jobs and skills = sustainable, high-value sector.

#timeslifesciencessummit #lifesciences
account_circle
Opportunity North East (ONE)(@Opportunity_NE1) 's Twitter Profile Photo

Professor Caroline Barelle CEO and Founder of
Elasmogen and Lucy Edwardes-Jones, Investor at
BGF discuss how long-term funding relationship unlocks the potential of Elasmogen’s next-generation soloMER drugs.

Professor @CarolineBarelle CEO and Founder of
@ElasmogenLtd and Lucy Edwardes-Jones, Investor at
@BGFinvestments discuss how long-term funding relationship unlocks the potential of Elasmogen’s next-generation soloMER drugs.

#timeslifesciencessummit #lifesciences
account_circle
Opportunity North East (ONE)(@Opportunity_NE1) 's Twitter Profile Photo

Tom Whipple speaks with Georgios Leontidis and Professor Noor Shaker about accelerating drug discovery with the power of artificial intelligence.

Using AI can advance product to market, optimise clinical trials and open up drug pathways.

@whippletom speaks with Georgios Leontidis and Professor Noor Shaker about accelerating drug discovery with the power of artificial intelligence.

Using AI can advance product to market, optimise clinical trials and open up drug pathways.

#timeslifesciencessummit #lifesciences
account_circle
Opportunity North East (ONE)(@Opportunity_NE1) 's Twitter Profile Photo

Deborah O'Neil discusses with Tom Whipple the routes to market, the importance of ensuring a tangible end user, embracing flexibility to abandon initial ideas lacking commercial viability and fostering a culture of creativity and innovation.

@debsoneil discusses with @whippletom the routes to market, the importance of ensuring a tangible end user, embracing flexibility to abandon initial ideas lacking commercial viability and fostering a culture of creativity and innovation. 

#timeslifesciencessummit #lifesciences
account_circle